Scotia Capital Inc. Teva Pharmaceutical Industries LTD Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Scotia Capital Inc. holds 12,916 shares of TEVA stock, worth $285,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,916

Previous 12,871 0.35%

Holding current value

$285,314

Previous $209,000 11.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.81 - $18.96 $711 - $853	45 Added 0.35%	12,916 $232,000
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $7,386 - $10,057	578 Added 4.7%	12,871 $209,000
Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $277 - $375	26 Added 0.21%	12,293 $173,000
Q4 2023 Feb 12, 2024	SELL	$8.12 - $10.63 $243 - $318	-30 Reduced 0.24%	12,267 $128,000
Q4 2022 Feb 09, 2023	SELL	$7.95 - $9.48 $2,583 - $3,081	-325 Reduced 2.57%	12,297 $112,000
Q3 2022 Nov 10, 2022	BUY	$6.86 - $11.95 $171 - $298	25 Added 0.2%	12,622 $102,000
Q2 2022 Aug 05, 2022	SELL	$7.38 - $10.4 $7,630 - $10,753	-1,034 Reduced 7.59%	12,597 $95,000
Q1 2022 May 09, 2022	BUY	$7.33 - $9.39 $16,375 - $20,977	2,234 Added 19.6%	13,631 $128,000
Q4 2021 Feb 11, 2022	BUY	$7.9 - $10.19 $1,271 - $1,640	161 Added 1.43%	11,397 $91,000
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $2,178 - $2,646	260 Added 2.37%	11,236 $109,000
Q2 2021 Aug 12, 2021	SELL	$9.9 - $11.56 $4,653 - $5,433	-470 Reduced 4.11%	10,976 $109,000
Q1 2021 May 06, 2021	SELL	$10.34 - $12.81 $10,226 - $12,669	-989 Reduced 7.95%	11,446 $132,000
Q4 2020 Feb 11, 2021	SELL	$8.61 - $11.04 $921 - $1,181	-107 Reduced 0.85%	12,435 $120,000
Q3 2020 Nov 12, 2020	SELL	$8.57 - $12.69 $34,562 - $51,178	-4,033 Reduced 24.33%	12,542 $113,000
Q2 2020 Aug 11, 2020	BUY	$8.12 - $13.12 $2,638 - $4,264	325 Added 2.0%	16,575 $209,000
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $10,623 - $21,358	1,588 Added 10.83%	16,250 $146,000
Q4 2019 Feb 13, 2020	SELL	$6.53 - $10.72 $16,122 - $26,467	-2,469 Reduced 14.41%	14,662 $144,000
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $2,383 - $3,715	-387 Reduced 2.21%	17,131 $118,000
Q2 2019 Aug 13, 2019	SELL	$8.12 - $15.72 $12,821 - $24,821	-1,579 Reduced 8.27%	17,518 $162,000
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $455,356 - $584,832	-29,227 Reduced 60.48%	19,097 $299,000
Q4 2018 Feb 11, 2019	SELL	$14.59 - $23.84 $133,498 - $218,136	-9,150 Reduced 15.92%	48,324 $745,000
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $2.09 Million - $2.55 Million	-99,411 Reduced 63.37%	57,474 $1.24 Million
Q2 2018 Aug 13, 2018	BUY	$16.77 - $24.71 $10,481 - $15,443	625 Added 0.4%	156,885 $2.64 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $1.74 Million - $2.31 Million	104,520 Added 202.01%	156,260 $2.67 Million
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $1.24 Million - $2.11 Million	-110,408 Reduced 68.09%	51,740 $981,000
Q3 2017 Nov 14, 2017	SELL	$15.41 - $32.17 $2.17 Million - $4.53 Million	-140,877 Reduced 46.49%	162,148 $2.85 Million
Q2 2017 Aug 15, 2017	BUY	N/A	303,025	303,025 $10.1 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Teva Pharmaceutical Industries LTD Transaction History